Bortezomib API Market Size Was Valued at USD 23.53 Million in 2022, and is Projected to Reach USD 33.46 Million by 2030, Growing at a CAGR of 4.5% From 2023-2030.
Bortezomib Active Pharmaceutical Ingredient, or Bortezomib API, is a chemical substance that serves as the key component in manufacturing the drug Bortezomib. This drug is frequently employed in the treatment of multiple myeloma, a...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian